Literature DB >> 17548615

TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses.

Laurent Genestier1, Morgan Taillardet, Paul Mondiere, Hanane Gheit, Chantal Bella, Thierry Defrance.   

Abstract

Naive murine B cells are known to proliferate and differentiate in response to LPS or CpG, which bind to TLR4 and TLR9, respectively. However, the naive murine B cell compartment is heterogeneous and comprises four different B cell subsets: B-1a, B-1b, marginal zone (MZ), and follicular (FO) B cells. B-1a, B-1b, and MZ B cells are specialized in the response to thymus-independent Ag, and FO B cells are involved in the response to thymus-dependent Ag. This study was undertaken to compare those four naive B cell subsets for their responses to TLR agonists. Quantitative RT-PCR analysis revealed that expression of TLR transcripts differs quantitatively but not qualitatively from one subset to the other. All TLR agonists, with the exception of flagellin and poly(I:C), stimulate B cell proliferation whatever the subset considered. However, TLR ligation leads to massive differentiation of B-1 and MZ B cells into mature plasma cells (PC) but only marginally promotes PC differentiation of FO B cells. Moreover, TLR stimulation strongly up-regulates expression of Blimp-1 and XBP-1(S), two transcription factors known to be instrumental in PC differentiation, in B-1 and MZ B cells but not in FO B cells. Altogether, our findings suggest that B-1 and MZ B cells are poised to PC differentiation in response to the microbial environment and that TLR agonists can be instrumental in stimulating Ab-mediated innate immune protection during microbial infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548615     DOI: 10.4049/jimmunol.178.12.7779

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  138 in total

Review 1.  Regulation of B-cell responses by Toll-like receptors.

Authors:  Edward P Browne
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

Review 2.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

Review 3.  Immunological function of Blimp-1 in dendritic cells and relevance to autoimmune diseases.

Authors:  Sun Jung Kim
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

4.  Hormonal milieu at time of B cell activation controls duration of autoantibody response.

Authors:  Venkatesh Jeganathan; Elena Peeva; Betty Diamond
Journal:  J Autoimmun       Date:  2014-03-28       Impact factor: 7.094

5.  Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance.

Authors:  Daniel B Harmon; Prasad Srikakulapu; Jennifer L Kaplan; Stephanie N Oldham; Chantel McSkimming; James C Garmey; Heather M Perry; Jennifer L Kirby; Thomas A Prohaska; Ayelet Gonen; Peter Hallowell; Bruce Schirmer; Sotirios Tsimikas; Angela M Taylor; Joseph L Witztum; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-02-11       Impact factor: 8.311

6.  Blimp-1/PRDM1 mediates transcriptional suppression of the NLR gene NLRP12/Monarch-1.

Authors:  Christopher A Lord; David Savitsky; Raquel Sitcheran; Kathryn Calame; Jo Rae Wright; Jenny Pan-Yun Ting; Kristi L Williams
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

7.  ATG5 regulates plasma cell differentiation.

Authors:  Kara L Conway; Petric Kuballa; Bernard Khor; Mei Zhang; Hai Ning Shi; Herbert W Virgin; Ramnik J Xavier
Journal:  Autophagy       Date:  2013-01-17       Impact factor: 16.016

8.  CD1d(hi)CD5⁺ B cells differentiate into antibody-secreting cells under the stimulation with calreticulin fragment.

Authors:  Tengteng Zhang; Yun Xia; Lijuan Zhang; Wanrong Bao; Chao Hong; Xiao-Ming Gao
Journal:  Protein Cell       Date:  2013-11-10       Impact factor: 14.870

9.  A p38 MAPK-MEF2C pathway regulates B-cell proliferation.

Authors:  Dustin Khiem; Jason G Cyster; John J Schwarz; Brian L Black
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-27       Impact factor: 11.205

10.  An Adjuvant That Increases Protective Antibody Responses to Polysaccharide Antigens and Enables Recall Responses.

Authors:  James P Phipps; Karen M Haas
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.